HER2 Support Group Forums - View Single Post - Updated clinical data from Phase 2 study evaluating oral ridaforolimus presented

News · 12-14-2009, 10:20 PM

ARIAD Pharmaceuticals, Inc. today announced the presentation of updated clinical data from its Phase 2 study evaluating oral ridaforolimus in combination with trastuzumab (Herceptin®) in patients with resistant, metastatic breast cancer.

More...

12-14-2009, 10:20 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,123	Updated clinical data from Phase 2 study evaluating oral ridaforolimus presented ARIAD Pharmaceuticals, Inc. today announced the presentation of updated clinical data from its Phase 2 study evaluating oral ridaforolimus in combination with trastuzumab (Herceptin®) in patients with resistant, metastatic breast cancer. More...